Form 8-K - Current report:
SEC Accession No. 0000950170-25-083830
Filing Date
2025-06-09
Accepted
2025-06-09 17:00:14
Documents
13
Period of Report
2025-06-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K asmb-20250605.htm   iXBRL 8-K 103958
2 EX-10.1 asmb-ex10_1.htm EX-10.1 8091
3 EX-10.2 asmb-ex10_2.htm EX-10.2 8330
4 EX-10.3 asmb-ex10_3.htm EX-10.3 8425
  Complete submission text file 0000950170-25-083830.txt   253359

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT asmb-20250605.xsd EX-101.SCH 30676
15 EXTRACTED XBRL INSTANCE DOCUMENT asmb-20250605_htm.xml XML 4711
Mailing Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35005 | Film No.: 251034886
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)